Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pirfenidone for chronic diabetic foot ulcers
NCT02222376Phase 3Completed
- Sponsor
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
- Start
- Oct 2013
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pirfenidone in diabetic foot ulcer (DFU), sponsored by Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Started Oct 2013; status: completed.
02
Drugs
pirfenidone
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT02222376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02222376.